First-Line Treatment of Vernal Keratoconjunctivitis

Clinical Overview

Vernal keratoconjunctivitis (VKC) is a recurrent bilateral inflammatory condition of the ocular surface with an allergic component. First-line management is directed at reducing trigger exposure and controlling ocular discomfort.

Treatment Approach

Management begins with steps to minimise allergen and irritant exposure. Antihistamine-based therapy and agents that act on mast-cell pathways are part of the approach…

Full structured regimen available below ↓

Instant Access to Structured Evidence-Based Regimens

References

General treatment measures for vernal/atopic conjunctivitis include modifying the environment to minimize exposure to allergens or irritants and using cool compresses and ocular lubricants.

Topical and oral antihistamines and topical mast-cell stabilizers can be useful to maintain comfort.

View source ↗